• Explore /
  • Poster
  • / Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.

Neoadjuvant chemotherapy with docetaxel plus oxaliplatin and S-1 for locally advanced, resectable gastric or gastro-esophageal junction adenocarcinoma: Short-term results from a phase II trial.

Abstract Poster

Authors

null

Tomono Kawase

Department of Surgery, Toyonaka Municipal Hospital, Toyonaka, Japan

Tomono Kawase , Yukinori Kurokawa , Noboru Kobayashi , Atsushi Takeno , Ryohei Kawabata , Tsuyoshi Takahashi , Makoto Yamasaki , Yuichiro Doki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

000017652

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 397)

Abstract #

397

Poster Bd #

F8

Abstract Disclosures

Similar Posters

First Author: Rixci Ramirez

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

First Author: Izuma Nakayama

First Author: Salah-Eddin Al-Batran

First Author: Ralf Hofheinz